– USA, CA – Satellite Healthcare, the leading nonprofit dialysis provider, today announced Jeffrey Goffman will be its next CEO, effective January 2, 2021, succeeding outgoing CEO Rick Barnett who announced his planned retirement in September.
Goffman brings nearly 30 years of health care industry leadership to Satellite, with expertise in physician practice management, large healthcare system joint ventures, ancillary services, and value-based care models.
“We are pleased to welcome Jeffrey Goffman as our next CEO, an industry veteran who understands the importance of expanding access to critical care services like dialysis,” said Board Chair, Christobel Selecky. “Jeff shares our commitment to fulfilling Satellite’s core mission of humanizing dialysis by bringing individualized dialysis care to patients in a friendlier, more comfortable environment.”
About Jeff Goffman
Before Satellite, Goffman served as CEO of Integrated Oncology Network for more than a decade. Goffman has been dedicated over the last 25 years to nonprofit missions and currently serves on the board of CureDuchenne and American Cancer Society’s CEO’s Against Cancer, of which he was the past chair for California.
“I am very excited and honored by the opportunity to lead Satellite Healthcare and our mission to make life better for people with kidney disease,” said Jeff Goffman. “Satellite Healthcare has a great opportunity to improve the quality and access to home dialysis care, reduce costs, and pioneer integrated value-based care models.”
About Satellite Healthcare
Satellite Healthcare has more than 80 locations across the country and serves more than 8,000 patients annually. Its more than 2,000 employees are committed to its vision of making life better for those living with kidney disease.
For more information: https://www.satellitehealth.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.